Result Summaries: ketoconazole
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 114568 | phase 4 | A PHASE 4, OPEN-LABEL STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% IN THE TREATMENT OF SEBORRHEIC DERMATITIS (0 citation(s)) |  |